Zydus Lifesciences Limited
ZYDUSLIFE
Ранг среди акций
#1746
Zydus Lifesciences Limited, an Indian enterprise founded in Ahmedabad in 1952,... Zydus Lifesciences Limited, an Indian enterprise founded in Ahmedabad in 1952, operates globally in the pharmaceutical and consumer goods sectors. Renamed from Cadila Healthcare Limited in February 2022, the company manages the entire lifecycle of pharmaceutical products, from research and development to manufacturing, marketing, and distribution. Its extensive reach covers India, the United States, Europe, Latin America, the Asia Pacific region, and Africa. The company's pharmaceutical division provides a broad spectrum of offerings, including finished dosage human formulations (such as generics, branded generics, and specialized treatments like biosimilars and vaccines), as well as active pharmaceutical ingredients (APIs). Zydus focuses on therapeutic areas like pain management, neurology, dermatology, and liver diseases, among others. Additionally, it is developing a pipeline of biological products aimed at conditions such as oncology, autoimmune disorders, nephrology, ophthalmology, inflammation, rheumatology, hepatology, and infectious diseases. In its consumer products segment, Zydus offers popular wellness brands including Complan, the EverYuth range of skincare products, Nycil, Glucon-D glucose powder, Nutralite, and the Nutralite Doodhshakti dairy product line. Beyond these core operations, the company is also involved in investment activities, animal health and veterinary services, pharmacy retail, and human resource supply and administration.
Цена акции
$12.30
Последняя синхронизация: 2026-10-21
Рыночная капитализация
$12.27B
Изменение (1 день)
0.06%
Изменение (1 год)
8.33%
Страна
IN
Торговля Zydus Lifesciences Limited (ZYDUSLIFE)
Категория
Healthcare
Прибыль Zydus Lifesciences Limited (ZYDUSLIFE)
Прибыль на Jun 2026 TTM: $674.03M
Согласно последним финансовым отчетам Zydus Lifesciences Limited, текущая прибыль компании составляет $674.03M. В 2024 году компания получила прибыль $590.92M, больше, чем прибыли за 2023, которая составила $326.63M. Отображаемая прибыль на этой странице — это прибыль до уплаты процентов и налогов, или просто EBIT.
История прибыли компании Zydus Lifesciences Limited с 2004 по 2026
Прибыль в конце каждого года
| Год | Прибыль | Изменить |
|---|---|---|
| 2026 (TTM) | $674.03M | -5.26% |
| 2025 | $711.42M | 20.39% |
| 2024 | $590.92M | 80.91% |
| 2023 | $326.63M | -14.04% |
| 2022 | $379.97M | 13.69% |
| 2021 | $334.22M | 65.19% |
| 2020 | $202.32M | -42.16% |
| 2019 | $349.80M | -4.85% |
| 2018 | $367.62M | 44.63% |
| 2017 | $254.19M | -21.37% |
| 2016 | $323.28M | 39.35% |
| 2015 | $231.99M | 47.59% |
| 2014 | $157.19M | 5.61% |
| 2013 | $148.84M | -4.97% |
| 2012 | $156.62M | -17.15% |
| 2011 | $189.05M | 40.60% |
| 2010 | $134.46M | 84.59% |
| 2009 | $72.84M | -9.87% |
| 2008 | $80.82M | 27.90% |
| 2007 | $63.19M | 59.18% |
| 2006 | $39.70M | 26.43% |
| 2005 | $31.40M | -10.04% |
| 2004 | $34.90M | 0.00% |
Прибыль схожих компаний или конкурентов
| Компания | Прибыль | Разница в прибыли | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 161.79% |
IN
|
